The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on August 24, 2026

Aug. 24, 2026

Approbation du changement de dénomination sociale et du regroupement d’actions

Indeterminate GlobeNewswire

Aug. 24, 2026

Globex Reports that Royalty Partner Radisson is Commencing an Advanced Underground Exploration Project at the O’Brien Project Where Globex Owns Two Royalties

Indeterminate GlobeNewswire

Aug. 24, 2026

XS.com Conquista o Prêmio de "Melhor Programa de Fidelidade para Parceiros" na Wealth Expo Mexico 2026

Indeterminate EIN Presswire

Aug. 24, 2026

XS.com gana el premio al "Mejor Programa de Fidelización para Socios" en Wealth Expo México 2026

Indeterminate EIN Presswire

Aug. 24, 2026

Greenland Mines Delivers Landmark S-K 1300 Mineral Resource Estimate for Sarfartoq in Greenland; First-Ever Indicated Resource and First Combined Open Pit/Underground Resource for the Critical Nd-Pr Magnet Rare Earths Project

Indeterminate GlobeNewswire

Aug. 24, 2026

GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

Aeroméxico Announces Intention to Submit Share Repurchase Program for Shareholder Approval

Indeterminate GlobeNewswire

Aug. 24, 2026

Alkeus Pharmaceuticals Announces Japan Ministry of Health, Labour and Welfare (MHLW) Has Granted Orphan Drug Designation to Gildeuretinol for Stargardt Disease

Indeterminate GlobeNewswire

Aug. 24, 2026

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

Indeterminate GlobeNewswire

Aug. 24, 2026

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Indeterminate GlobeNewswire

Aug. 24, 2026

ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE

Indeterminate GlobeNewswire

Aug. 24, 2026

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

Indeterminate GlobeNewswire

Aug. 24, 2026

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Indeterminate GlobeNewswire

Aug. 24, 2026

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

DEEP SEA MINERALS CORP. TO ATTEND DIB ACCELERATOR 2026 IN PHILADELPHIA

Indeterminate GlobeNewswire

Aug. 24, 2026

Lithium Argentina Finalizes PPG Joint Venture; Announces $180M Strategic Investment from Ganfeng

Indeterminate GlobeNewswire

Aug. 24, 2026

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Indeterminate GlobeNewswire

Aug. 24, 2026

Surge Copper Provides Mid-Season Berg Update and Advances Environmental Assessment Preparations

Indeterminate GlobeNewswire

Aug. 24, 2026

Mesoblast Financial Results and Corporate Update Webcast

Indeterminate GlobeNewswire

Aug. 24, 2026

Goliath’s 2026 Drilling Expands Golden Gate Zone From 0.85 Km² To 1.17 Km² And Bonanza Zone From 1.27 Km² to 1.51 Km² And Remains Open For Expansion, Drilling Continues On The High-Grade Gold Surebet Discovery, Golden Triangle, B.C.

Indeterminate GlobeNewswire